Trius Therapeutics is a great local company which recently had an initial public offering (IPO), quite a feat in this economy. What is the secret to their success? They focus on antibacterials for life threatening applications, and have used a creative combination of licensing and funding to build a strong portfolio in that area. Working with bacterial proteins helps Trius to leverage structure-based drug design (SBDD) technologies to efficiently optimize lead compounds. Dr. John Finn, Trius’ Chief Scientific Officer (bio), will present a talk titled “Innovative Antibacterial Drugs by Design; The Trius Therapeutics Story,” and as always you’ll have plenty of time to talk with him and others from Trius. Register here.
Sponsorships are available and affordable, with a speaking option available, contact us!
Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology August Event Featuring Trius Therapeutics
When: Tuesday, October 26th, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $25/$20 Academic
For more information about the event: http://sdbn.org/october
Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks. Park on the street or in the structure just past (south of) Tango del Rey. DO NOT park in the Science Center lot.